Monitoring drug therapy at the point-of-care
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Presentation
- By: WIDMER, Nicolas (Centre Hospitalier Universitaire Vaudois and University of Lausanne, Division of Clinical Pharmacology, Lausanne, Switzerland)
Monitoring drug therapy consists in repeated testing to guide and adjust the pharmacotherapy of a chronic or acute condition. The monitored variable is either the relevant clinical outcome itself or a valid surrogate used to predict treatment success or toxicity. The circulating drug concentration is the classical pharmacokinetic surrogate in what.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.